Anne Beiter

Learn More
Seven postlinguistically deaf adults implanted with the Nucleus Multi-Electrode Cochlear Implant participated in an evaluation of speech perception performance with three speech processors: the Wearable Speech Process (WSP III), a prototype of the Mini Speech Processor, and the Mini Speech Processor. The first experiment was performed with the prototype and(More)
Results from 80 pediatric subjects with 12 months of experience wearing the Nucleus multichannel cochlear implant are presented. The data suggest that children demonstrate statistically and clinically significant benefit across a broad spectrum of abilities with the implant. Significant postoperative improvement was demonstrated by 66 percent (51 of 77), 63(More)
Consonant production was investigated in 29 children participating in the federal Food and Drug Administration's clinical trials of the Nucleus WSP-III cochlear implant. Speech samples were collected preimplant and 1 year postimplant. A significantly greater number of children produced stop, nasal, fricative, and glide consonants postimplant. Voiced stop(More)
The purpose of this study is to report on five speech production protocols collected as part of the Food and Drug Administration's Clinical Trials for the Nucleus multichannel cochlear implant. Sixty-one children, ranging in age from 2.4 years to 17.8 years, participated. Speech measures included nonsegmental and segmental portions of the Phonetic Level(More)
Electrical auditory brain stem responses (EABR) and electrical middle latency responses (EMLR) were recorded from patients who had received the Nucleus multichannel cochlear implant system. Twenty-five sequential patients had either intraoperative or outpatient EABR testing. We also recorded EMLRs from several outpatients. EABR results were consistent among(More)
BACKGROUND While published data exist regarding cochlear implant (CI) outcomes from large academic programs, evidence of benefit based on national, multicenter clinical trials is needed for information regarding typical patient outcomes of devices implanted by U.S. centers representing larger academic to smaller hospital-based programs. PURPOSE This(More)
  • 1